FIELD: medicine.
SUBSTANCE: method involves exposing biologically active points and auxiliary points to electromagnetic radiation produced by line spectrum source. Material containing platinum is used as source glow material when acting upon DV-8, BL-47 and RN 15 points and material containing osmium is used when treating GB 24 and BL 18 points. Material containing platinum is used as source glow material when acting upon the first auxiliary points, material containing osmium is used when treating the third auxiliary points and material containing nickel is used when treating the second and the fourth auxiliary points.
EFFECT: enhanced effectiveness in controlling action intensity in objective way.
1 dwg
